Francesca Santini, research fellow at Merck’s automated biotechnology facility, pulls up an image of muscle cells, in North Wales, Pa., May 22, 2010. Ten years after the start of the Human Genome Project experts say the project has bogged down the drug industry with information overload and has yielded few medical benefits. (Laura Pedrick/The New York Times)